Rayner’s international Executive Team is deeply committed to realising the company’s global potential. With almost half of the team joining Rayner through 2012-2013, the company is led by a diverse mix of people with both fresh ideas and in-depth knowledge of our business, people and customers. We believe this gives our team the ideal blend of skills and expertise.
Tim joined the Board in May 2014. Tim has spent many years in the ophthalmic market and brings to Rayner extensive knowledge of medical devices, ophthalmic services and strategic investment.
Tim was a founder and European VP of Advanced Medical Optics which was spun out of Allergan Inc, listed on the NYSE and subsequently acquired by Abbott Inc. More recently he was CEO of Moonray Healthcare, a private equity fund within Fidelity Worldwide Investments in which Optegra was a landmark investment. Tim led a team which grew Optegra into a leading worldwide provider of eye surgery centres operating from 23 specialist eye hospitals across Europe and Asia.
Tim has a passion for swimming, cycling and running and regularly competes in triathlons.
Darren joined the Board in August 2014 with 8 years’ experience as a CFO in public and private companies. Following an MSc in Theoretical Physics, Darren worked in new product development for AEA Technology before joining Arthur Andersen (later Deloitte) to become a chartered accountant. Once qualified he worked for IP Group plc as part of a small team helping commercialise innovative university technologies. He then joined one of these spin-out companies, Summit Corporation, which specialises in developing drugs for muscular dystrophy and TB. The company was successfully floated in 2004 on the AIM market.
Darren’s most recent position was as CFO at Gama Aviation, an aviation and engineering company with operations around the world and revenues over $200m. In each of his recent roles, Darren has helped the companies grow through investment and acquisition.
Darren is a keen cyclist who can be found climbing the Sussex hills most weekends.
David joined Rayner in August 2017. David has spent over 30 years working in the Medical Device market and brings to Rayner extensive knowledge of Regulatory, Quality, Manufacturing, and Distributing medical devices.
David has had over 5 years’ experience on Stryker’ s European leadership team with responsibility for Operations, and RA/QA. During this time the European leadership team transformed the business, significantly improving sales and operational performance.
One significant achievement was the restructure of the operations team which through improved supply chain processes significantly improved service levels to customers, while reducing the inventory.
David is a very keen golfer and runner in his spare time.
Vice President - International
Cary was appointed to the Board in 2005. He subsequently joined our intraocular lens business in 2007, initially as UK Commercial Director where he achieved year-on-year double-digit growth. Cary is currently VP International.
Prior to joining Rayner, Cary enjoyed a career in banking and his last role was as Sales Director for Barclays Premier banking.
Cary’s great grandfather was Jean-Baptiste Reiner, one of the two original founders of Rayner in 1910 and accordingly Cary has a very particular connection with the Rayner business.
Cary is married to Laura, has 3 children (including a set of twins) and a dog, Honey.
Nat joined Rayner in 2004 with a degree in Mechanical Engineering, initially gaining experience across a diverse range of areas including new product development and design control, but also risk management, equipment design & validation, clinical writing and post market surveillance. More recently he achieved a Certificate in Company Direction (Dist) from the IoD and in his current role leads a high-performing team of researchers, engineers, scientists and project managers who have successfully designed and launched 10+ market-leading intraocular lenses since 2016 (including the Rayner RayOne, Trifocal and EMV families).
Nat’s current focus is building on Rayner’s reputation as an innovation leader in premium intraocular lenses and delivery systems, to expand the company research & product development program into new and exciting areas of ophthalmology.
Alongside looking after his two young children, Nat’s interests away from work include football, bouldering and custom PC building!
Vice President - Europe
James joined Rayner in 2008 from Pfizer where he specialised in pharmaceutical sales. In addition to the UK sales organisation, James is responsible for Rayner’s wholly owned subsidiary companies across Europe.
In December 2019, James relocated back to the UK from New York where he spent two years overseeing the establishment of our direct US presence Rayner Surgical Inc. James is well versed in similar projects having led on Rayner’s direct entry into Iberia, Italy and Switzerland, and as recently as 2022, Poland and France. James has several years’ life sciences experience, 14 of which have been at Rayner and now as VP – Europe, will lead commercial execution, launching our pipeline of products and in expanding our direct presence to new markets.
He is a Business Postgraduate from the University of Warwick and holds a BA (Hons) degree from the University of Central Lancashire. As a senior member of Rayner’s commercial team, James can be relied on to deliver the objectives set for growth in Europe’s largest IOL markets.
James is a keen runner and enjoys spending his spare time exploring the many trails in Surrey.
Vice President - Marketing
Chris joined Rayner in February 2021 as Vice President of Marketing, responsible for the groups marketing and clinical departments globally.
Since graduating Chris has spent over 20 years working in the medical device industry, with the last 15 years in global ophthalmology. Chris’s marketing career started at 3M Health Care, spending 5 valuable years in their UK medical markets division, followed by 5 years with Bausch & Lomb surgical, where Chris was responsible for marketing across EMEA before being relocated to the Bausch Surgical’s global headquarters in Southern California to introduce the MICS Platform and head up global marketing. Since his time in the US, Chris has led the global commercialisation of new and innovative technology such as the KAMRA inlay and IC-8 IOL from AcuFocus, led a turnaround for Optos (Nikon Medical) in the UK and Nordics and launched the EyeMax Mono IOL on behalf of Syneos Health Commercial Solutions.
While not living medical devices, Chris enjoys spending time with his young family, being outdoors and both watching and playing sport as often as possible.
Claire joined Rayner in December 2020 with a strong and varied HR generalist and Organisation Development background gained in aerospace, manufacturing and medical device sectors. Claire brings to Rayner international experience of driving high performance work cultures and transformational change programmes, including mergers and acquisitions, with a strong focus on talent management.
Claire gained 7 years experience at CR Bard (now Becton Dickinson) where she held a number of regional HR Director roles across EMEA and EEMEA and joins us most recently from Acro Aircraft Seating who design, engineer and manufacture aircraft interiors where Claire held a key role on the executive leadership team and delivered business transformation initiatives leading to the successful relocation of the business to a new facility in Northampton.
Claire is a Chartered Fellow of the Chartered Institute of Personnel and Development and in her spare time she enjoys yoga, horse riding and long walks in the countryside with her dog!
VP Corporate Development
Rob joined Rayner in November 2021. Rob has spent 18 years working in the finance industry and ophthalmology clinical practice.
Rob spent over a decade advising healthcare companies on strategic and financial matters. He was previously at William Blair where he was the Head of Medtech in Europe. Prior to William Blair, Rob was a member of the Global Healthcare M&A teams at Perella Weinberg Partners, Nomura and commenced his banking career at Lehman Brothers. He holds a medical and science degree from Imperial College and trained as an ophthalmic surgeon practising in the UK.
Rob is a keen tennis player and between matches likes spending time with his young children.
Alan started at Rayner in December 2015, joining as a senior legal counsel with a combination of both private practice and in-house experience. Alan is dual-qualified as a solicitor and trade mark attorney, and is an associate member of the Chartered Governance Institute UK & Ireland.
Whilst in private practice, Alan gained significant experience as an associate solicitor in corporate, compliance, commercial and intellectual property matters at a major regional law firm, representing clients across a number of industries. Alan’s in-house experience prior to joining Rayner was as legal counsel at a research-intensive university, advising on a broad range of commercial/IP arrangements including industry collaborations, clinical trials, IP licensing, consortium and investment agreements. Since Alan joined Rayner, the business has grown at an incredible pace – during this time Alan has overseen the M&A activity of the group, as well as managing the expanding legal operations required of a high-growth business.
Whilst away from work, Alan enjoys keeping active with his young family, spending time in the gym and exploring the South Downs.
Sign up to receive carefully selected news and information from Rayner.
Rayner is a British medical device manufacturer.
Make an Enquiry